$ALQA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adynxx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adynxx, Inc.. Get notifications about new insider transactions in Adynxx, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2019 | ALQA | Alliqua BioMedical ... | ABEL STAN E | Director | Option Exercise | A | 3.06 | 27,940 | 85,496 | 27,940 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | ABEL STAN E | Director | Option Exercise | A | 1.39 | 198 | 275 | 198 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | ABEL STAN E | Director | Grant | A | 0.00 | 54,117 | 0 | 54,117 | 0 to 54.1 K |
May 07 2019 | ALQA | Alliqua BioMedical ... | WEBER ECKARD | Director | Option Exercise | A | 3.06 | 55,879 | 170,990 | 55,879 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | WEBER ECKARD | Director | Option Exercise | A | 1.39 | 396 | 550 | 396 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | WEBER ECKARD | Director | Grant | A | 0.00 | 85,254 | 0 | 85,254 | 0 to 85.3 K |
May 07 2019 | ALQA | Alliqua BioMedical ... | Podlesak Dennis | Director | Option Exercise | A | 3.06 | 55,879 | 170,990 | 55,879 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | Podlesak Dennis | Director | Option Exercise | A | 1.39 | 396 | 550 | 396 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | Podlesak Dennis | Director | Grant | A | 0.00 | 85,254 | 0 | 85,254 | 0 to 85.3 K |
May 07 2019 | ALQA | Alliqua BioMedical ... | MAMET JULIEN | CHIEF SCIENTIFIC OF ... | Option Exercise | A | 3.06 | 158,149 | 483,936 | 158,149 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | MAMET JULIEN | CHIEF SCIENTIFIC OF ... | Option Exercise | A | 1.39 | 33 | 46 | 33 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | MAMET JULIEN | CHIEF SCIENTIFIC OF ... | Grant | A | 0.00 | 240,454 | 0 | 240,454 | 0 to 240.5 K |
May 07 2019 | ALQA | Alliqua BioMedical ... | Manning Donald C. | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 3.06 | 56,407 | 172,605 | 56,407 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | Manning Donald C. | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.39 | 3,943 | 5,481 | 3,943 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | Manning Donald C. | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.39 | 7,887 | 10,963 | 7,887 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | Manning Donald C. | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.11 | 23,858 | 26,482 | 23,858 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | ORR RICK | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 3.06 | 95,417 | 291,976 | 95,417 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | ORR RICK | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.39 | 661 | 919 | 661 | |
May 07 2019 | ALQA | Alliqua BioMedical ... | ORR RICK | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 142,090 | 0 | 142,090 | 0 to 142.1 K |
Sep 25 2017 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Payment of Exercise | F | 0.42 | 67,536 | 28,365 | 558,822 | 626.4 K to 558.8 K (-10.78 %) |
Sep 25 2017 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Payment of Exercise | F | 0.42 | 70,833 | 29,750 | 476,421 | 547.3 K to 476.4 K (-12.94 %) |
Sep 25 2017 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Payment of Exercise | F | 0.42 | 69,978 | 29,391 | 506,601 | 576.6 K to 506.6 K (-12.14 %) |
Jul 05 2017 | ALQA | Alliqua BioMedical ... | WAGNER MARK T | Director | Option Exercise | A | 0.37 | 90,000 | 33,300 | 90,000 | |
Jul 05 2017 | ALQA | Alliqua BioMedical ... | LEONE JOSEPH M | Director | Option Exercise | A | 0.37 | 90,000 | 33,300 | 90,000 | |
Jul 05 2017 | ALQA | Alliqua BioMedical ... | Sklar Jeffrey | Director | Option Exercise | A | 0.37 | 90,000 | 33,300 | 90,000 | |
Jul 03 2017 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 0.37 | 90,000 | 33,300 | 90,000 | |
Jul 03 2017 | ALQA | Alliqua BioMedical ... | RESTANI GARY C | Director | Option Exercise | A | 0.37 | 90,000 | 33,300 | 90,000 | |
Jun 29 2017 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 1,994,535 | 1.7 M to 2 M (+17.70 %) |
Jun 28 2017 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Grant | A | 0.00 | 100,000 | 0 | 576,579 | 476.6 K to 576.6 K (+20.98 %) |
Jun 28 2017 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Grant | A | 0.00 | 100,000 | 0 | 626,358 | 526.4 K to 626.4 K (+19.00 %) |
Jun 28 2017 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 547,254 | 447.3 K to 547.3 K (+22.36 %) |
Jun 26 2017 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 500,000 | 0 | 1,694,535 | 1.2 M to 1.7 M (+41.86 %) |
Jun 26 2017 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Grant | A | 0.00 | 205,715 | 0 | 447,254 | 241.5 K to 447.3 K (+85.17 %) |
Jun 26 2017 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Grant | A | 0.00 | 205,715 | 0 | 476,579 | 270.9 K to 476.6 K (+75.95 %) |
Jun 26 2017 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Grant | A | 0.00 | 205,715 | 0 | 526,358 | 320.6 K to 526.4 K (+64.16 %) |
Jun 26 2017 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Buy | J | 0.00 | 100,000 | 0 | 786,750 | 686.8 K to 786.8 K (+14.56 %) |
Jun 21 2017 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Payment of Exercise | F | 0.37 | 10,032 | 3,712 | 270,864 | 280.9 K to 270.9 K (-3.57 %) |
Apr 13 2017 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Buy | J | 0.00 | 296,277 | 0 | 7,342,377 | 7 M to 7.3 M (+4.20 %) |
Apr 04 2017 | ALQA | Alliqua BioMedical ... | WAGNER MARK T | Director | Buy | J | 0.67 | 75,876 | 50,837 | 323,802 | 247.9 K to 323.8 K (+30.60 %) |
Apr 04 2017 | ALQA | Alliqua BioMedical ... | WAGNER MARK T | Director | Buy | P | 0.40 | 62,500 | 25,000 | 70,500 | 8 K to 70.5 K (+781.25 %) |
Apr 04 2017 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Buy | P | 0.40 | 75,000 | 30,000 | 320,643 | 245.6 K to 320.6 K (+30.53 %) |
Apr 04 2017 | ALQA | Alliqua BioMedical ... | LEONE JOSEPH M | Director | Buy | P | 0.40 | 25,000 | 10,000 | 43,823 | 18.8 K to 43.8 K (+132.82 %) |
Apr 04 2017 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Buy | P | 0.40 | 50,000 | 20,000 | 280,896 | 230.9 K to 280.9 K (+21.65 %) |
Apr 04 2017 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Buy | P | 0.40 | 250,000 | 100,000 | 1,194,535 | 944.5 K to 1.2 M (+26.47 %) |
Mar 01 2017 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 0.50 | 4,000,000 | 2,000,000 | 7,046,100 | 3 M to 7 M (+131.32 %) |
Mar 01 2017 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Buy | P | 0.50 | 400,000 | 200,000 | 686,750 | 286.8 K to 686.8 K (+139.49 %) |
May 20 2016 | ALQA | Alliqua BioMedical ... | WAGNER MARK T | Director | Buy | J | 2.61 | 73,893 | 192,861 | 247,926 | 174 K to 247.9 K (+42.46 %) |
May 13 2016 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 944,535 | 644.5 K to 944.5 K (+46.55 %) |
May 13 2016 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Grant | A | 0.00 | 100,000 | 0 | 245,643 | 145.6 K to 245.6 K (+68.66 %) |
May 13 2016 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Grant | A | 0.00 | 100,000 | 0 | 230,896 | 130.9 K to 230.9 K (+76.40 %) |
May 13 2016 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 241,539 | 141.5 K to 241.5 K (+70.65 %) |
May 13 2016 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 0.86 | 45,000 | 38,700 | 45,000 | |
May 13 2016 | ALQA | Alliqua BioMedical ... | Sklar Jeffrey | Director | Option Exercise | A | 0.86 | 45,000 | 38,700 | 45,000 | |
May 13 2016 | ALQA | Alliqua BioMedical ... | WAGNER MARK T | Director | Option Exercise | A | 0.86 | 45,000 | 38,700 | 45,000 | |
May 13 2016 | ALQA | Alliqua BioMedical ... | RESTANI GARY C | Director | Option Exercise | A | 0.86 | 45,000 | 38,700 | 45,000 | |
May 13 2016 | ALQA | Alliqua BioMedical ... | LEONE JOSEPH M | Director | Option Exercise | A | 0.86 | 45,000 | 38,700 | 45,000 | |
Feb 11 2016 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Grant | A | 0.00 | 14,384 | 0 | 130,896 | 116.5 K to 130.9 K (+12.35 %) |
Feb 11 2016 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Grant | A | 0.00 | 24,658 | 0 | 141,539 | 116.9 K to 141.5 K (+21.10 %) |
Feb 11 2016 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 59,932 | 0 | 644,535 | 584.6 K to 644.5 K (+10.25 %) |
Feb 11 2016 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Grant | A | 0.00 | 24,658 | 0 | 145,643 | 121 K to 145.6 K (+20.38 %) |
Nov 12 2015 | ALQA | Alliqua BioMedical ... | Sklar Jeffrey | Director | Buy | P | 2.95 | 1,500 | 4,425 | 24,357 | 22.9 K to 24.4 K (+6.56 %) |
Nov 10 2015 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Buy | P | 3.04 | 5,000 | 15,200 | 116,881 | 111.9 K to 116.9 K (+4.47 %) |
Nov 09 2015 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Buy | P | 2.97 | 5,000 | 14,850 | 120,985 | 116 K to 121 K (+4.31 %) |
Nov 09 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Buy | P | 2.92 | 8,650 | 25,258 | 584,603 | 576 K to 584.6 K (+1.50 %) |
Nov 09 2015 | ALQA | Alliqua BioMedical ... | LEONE JOSEPH M | Director | Buy | P | 2.78 | 3,500 | 9,730 | 18,823 | 15.3 K to 18.8 K (+22.84 %) |
Nov 09 2015 | ALQA | Alliqua BioMedical ... | WAGNER MARK T | Director | Buy | P | 2.88 | 8,000 | 23,040 | 8,000 | 0 to 8 K |
Nov 09 2015 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Buy | P | 2.91 | 14,000 | 40,740 | 286,750 | 272.8 K to 286.8 K (+5.13 %) |
Nov 09 2015 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | Chief Strategy & Ma ... | Buy | P | 2.95 | 10,000 | 29,500 | 116,512 | 106.5 K to 116.5 K (+9.39 %) |
Aug 10 2015 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Buy | P | 5.02 | 2,500 | 12,550 | 111,881 | 109.4 K to 111.9 K (+2.29 %) |
Jul 06 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 5.35 | 19,191 | 102,672 | 575,953 | 595.1 K to 576 K (-3.22 %) |
Jun 17 2015 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Option Exercise | A | 5.25 | 100,000 | 525,000 | 100,000 | |
Jun 17 2015 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Payment of Exercise | F | 5.25 | 13,488 | 70,812 | 106,512 | 120 K to 106.5 K (-11.24 %) |
Jun 17 2015 | ALQA | Alliqua BioMedical ... | Pionati Pellegrino | See Remarks | Grant | A | 0.00 | 120,000 | 0 | 120,000 | 0 to 120 K |
Jun 10 2015 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Buy | P | 5.25 | 3,000 | 15,735 | 115,985 | 113 K to 116 K (+2.66 %) |
Jun 02 2015 | ALQA | Alliqua BioMedical ... | WAGNER MARK T | Director | Option Exercise | A | 4.95 | 15,000 | 74,250 | 15,000 | |
Jun 02 2015 | ALQA | Alliqua BioMedical ... | WAGNER MARK T | Director | Grant | A | 0.00 | 174,033 | 0 | 174,033 | 0 to 174 K |
May 28 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Buy | P | 4.65 | 10,000 | 46,458 | 595,144 | 585.1 K to 595.1 K (+1.71 %) |
May 20 2015 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Buy | P | 4.34 | 2,500 | 10,850 | 109,381 | 106.9 K to 109.4 K (+2.34 %) |
May 08 2015 | ALQA | Alliqua BioMedical ... | RESTANI GARY C | Director | Option Exercise | A | 4.73 | 15,000 | 70,950 | 15,000 | |
May 08 2015 | ALQA | Alliqua BioMedical ... | LEONE JOSEPH M | Director | Option Exercise | A | 4.73 | 15,000 | 70,950 | 15,000 | |
May 08 2015 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 4.73 | 15,000 | 70,950 | 15,000 | |
May 07 2015 | ALQA | Alliqua BioMedical ... | AFRICK ANDREW | Director | Option Exercise | A | 4.73 | 15,000 | 70,950 | 15,000 | |
May 07 2015 | ALQA | Alliqua BioMedical ... | Sklar Jeffrey | Director | Option Exercise | A | 4.73 | 15,000 | 70,950 | 15,000 | |
May 04 2015 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 4.55 | 659,340 | 2,999,997 | 3,046,100 | 2.4 M to 3 M (+27.62 %) |
Apr 03 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 5.19 | 20,590 | 106,862 | 585,144 | 605.7 K to 585.1 K (-3.40 %) |
Mar 10 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 5.29 | 7,673 | 40,590 | 605,734 | 613.4 K to 605.7 K (-1.25 %) |
Mar 10 2015 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Payment of Exercise | F | 5.29 | 759 | 4,015 | 106,881 | 107.6 K to 106.9 K (-0.71 %) |
Mar 10 2015 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Payment of Exercise | F | 5.29 | 2,225 | 11,770 | 112,985 | 115.2 K to 113 K (-1.93 %) |
Feb 09 2015 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Option Exercise | A | 6.23 | 115,000 | 716,450 | 115,000 | |
Feb 09 2015 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 107,640 | 7.6 K to 107.6 K (+1,308.90 %) |
Feb 09 2015 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Option Exercise | A | 6.23 | 115,000 | 716,450 | 115,000 | |
Feb 09 2015 | ALQA | Alliqua BioMedical ... | BARTON BRADFORD | Chief Operating Off ... | Grant | A | 0.00 | 100,000 | 0 | 115,210 | 15.2 K to 115.2 K (+657.46 %) |
Feb 09 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Option Exercise | A | 6.23 | 115,000 | 716,450 | 115,000 | |
Feb 09 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 613,407 | 313.4 K to 613.4 K (+95.72 %) |
Jan 05 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 5.30 | 21,681 | 114,909 | 313,407 | 335.1 K to 313.4 K (-6.47 %) |
Oct 02 2014 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 4.84 | 20,552 | 99,472 | 335,088 | 355.6 K to 335.1 K (-5.78 %) |
Sep 16 2014 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Buy | P | 4.94 | 2,000 | 9,880 | 7,640 | 5.6 K to 7.6 K (+35.46 %) |
Jul 23 2014 | ALQA | Alliqua BioMedical ... | RESTANI GARY C | Director | Option Exercise | A | 5.29 | 7,000 | 37,030 | 7,000 | |
Sep 04 2014 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | M | 4.24 | 23,500 | 99,640 | 174,031 | |
Sep 04 2014 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Buy | M | 4.24 | 23,500 | 99,640 | 272,750 | 249.3 K to 272.8 K (+9.43 %) |
Jul 23 2014 | ALQA | Alliqua BioMedical ... | AFRICK ANDREW | Director | Option Exercise | A | 5.29 | 7,000 | 37,030 | 7,000 | |
Jul 14 2014 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 5.74 | 20,367 | 116,907 | 355,640 | 376 K to 355.6 K (-5.42 %) |
Jun 10 2014 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | M | 4.24 | 23,500 | 99,640 | 4,719 | |
Jun 10 2014 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Buy | M | 4.24 | 23,500 | 99,640 | 249,250 | 225.8 K to 249.3 K (+10.41 %) |
May 13 2014 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Buy | P | 6.92 | 3,000 | 20,760 | 5,640 | 2.6 K to 5.6 K (+113.64 %) |
Apr 15 2014 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | A | 10.50 | 142,857 | 1,499,999 | 142,857 | |
Apr 15 2014 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 7.00 | 714,286 | 5,000,002 | 2,386,760 | 1.7 M to 2.4 M (+42.71 %) |
Apr 03 2014 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 8.25 | 20,186 | 166,535 | 376,007 | 396.2 K to 376 K (-5.09 %) |
Mar 19 2014 | ALQA | Alliqua BioMedical ... | STEFANSKY DAVID | Director | Option Exercise | A | 8.97 | 5,000 | 44,850 | 5,000 | |
Mar 10 2014 | ALQA | Alliqua BioMedical ... | Pearsen Kenneth D. | Director | Option Exercise | A | 9.00 | 5,000 | 45,000 | 5,000 | |
Mar 10 2014 | ALQA | Alliqua BioMedical ... | LEONE JOSEPH M | Director | Option Exercise | A | 9.00 | 5,000 | 45,000 | 5,000 | |
Mar 10 2014 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 9.00 | 5,000 | 45,000 | 5,000 | |
Mar 10 2014 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Option Exercise | A | 9.00 | 70,000 | 630,000 | 70,000 | |
Mar 10 2014 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Grant | A | 0.00 | 2,640 | 0 | 2,640 | 0 to 2.6 K |
Mar 10 2014 | ALQA | Alliqua BioMedical ... | Sklar Jeffrey | Director | Option Exercise | A | 9.00 | 5,000 | 45,000 | 5,000 | |
Mar 10 2014 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 17,824 | 0 | 396,193 | 378.4 K to 396.2 K (+4.71 %) |
Jan 28 2014 | ALQA | Alliqua BioMedical ... | LONDONER KENNETH L | Director | Option Exercise | A | 4.38 | 38,095 | 166,856 | 76,190 | |
Jan 28 2014 | ALQA | Alliqua BioMedical ... | LONDONER KENNETH L | Director | Option Exercise | A | 4.38 | 38,095 | 166,856 | 38,095 | |
Jan 17 2014 | ALQA | Alliqua BioMedical ... | SAPIRSTEIN JAMES | CEO, Therapeutics D ... | Payment of Exercise | F | 8.18 | 7,104 | 58,111 | 31,662 | 38.8 K to 31.7 K (-18.33 %) |
Jan 17 2014 | ALQA | Alliqua BioMedical ... | SAPIRSTEIN JAMES | CEO, Therapeutics D ... | Grant | A | 0.00 | 17,688 | 0 | 38,766 | 21.1 K to 38.8 K (+83.92 %) |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | ROSENBLUM RICHARD | Director | Option Exercise | D | 6.34 | 11,429 | 72,460 | 0 | |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | ROSENBLUM RICHARD | Director | Option Exercise | D | 9.19 | 114,286 | 1,050,288 | 0 | |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | ROSENBLUM RICHARD | Director | Option Exercise | D | 8.75 | 38,095 | 333,331 | 0 | |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | ROSENBLUM RICHARD | Director | Option Exercise | D | 8.75 | 114,286 | 1,000,003 | 0 | |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | ROSENBLUM RICHARD | Director | Grant | A | 0.00 | 194,667 | 0 | 819,307 | 624.6 K to 819.3 K (+31.16 %) |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | STEFANSKY DAVID | Director | Option Exercise | D | 6.34 | 11,429 | 72,460 | 0 | |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | STEFANSKY DAVID | Director | Option Exercise | D | 9.19 | 114,286 | 1,050,288 | 0 | |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | STEFANSKY DAVID | Director | Option Exercise | D | 8.75 | 38,095 | 333,331 | 0 | |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | STEFANSKY DAVID | Director | Option Exercise | D | 8.75 | 114,286 | 1,000,003 | 0 | |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | STEFANSKY DAVID | Director | Grant | A | 0.00 | 194,667 | 0 | 908,506 | 713.8 K to 908.5 K (+27.27 %) |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 6.99 | 19,245 | 134,523 | 378,369 | 397.6 K to 378.4 K (-4.84 %) |
Jan 08 2014 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 369,395 | 0 | 397,614 | 28.2 K to 397.6 K (+1,309.03 %) |
Dec 24 2013 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Option Exercise | A | 6.82 | 730,535 | 4,982,249 | 730,535 | |
Dec 23 2013 | ALQA | Alliqua BioMedical ... | SAPIRSTEIN JAMES | CEO, Alliqua Biomed ... | Payment of Exercise | F | 4.46 | 14,299 | 63,774 | 21,078 | 35.4 K to 21.1 K (-40.42 %) |
Dec 23 2013 | ALQA | Alliqua BioMedical ... | SAPIRSTEIN JAMES | CEO, Alliqua Biomed ... | Grant | A | 0.00 | 35,377 | 0 | 35,377 | 0 to 35.4 K |
Dec 16 2013 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 8.75 | 57,143 | 500,001 | 57,143 | |
Nov 15 2013 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Option Exercise | A | 0.08 | 5,124,181 | 409,934 | 5,124,181 | |
Nov 13 2013 | ALQA | Alliqua BioMedical ... | Harborview Advisors, LLC | Director | Grant | A | 0.00 | 8,144,719 | 0 | 44,021,018 | 35.9 M to 44 M (+22.70 %) |
Sep 05 2013 | ALQA | Alliqua BioMedical ... | BERGER STEVEN C | CFO, Treasurer and ... | Option Exercise | A | 0.10 | 5,000,000 | 500,000 | 5,000,000 | |
Sep 05 2013 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Option Exercise | A | 0.20 | 2,700,000 | 540,000 | 2,700,000 | |
Sep 05 2013 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Option Exercise | A | 0.15 | 2,700,000 | 405,000 | 2,700,000 | |
Sep 05 2013 | ALQA | Alliqua BioMedical ... | POSNER BRIAN M | Chief Financial Off ... | Option Exercise | A | 0.10 | 2,700,000 | 270,000 | 2,700,000 | |
Jul 25 2013 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 0.25 | 9,073,334 | 2,268,334 | 9,073,334 | |
Jul 25 2013 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 0.20 | 9,073,333 | 1,814,667 | 9,073,333 | |
Jul 25 2013 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 0.15 | 9,073,333 | 1,361,000 | 9,073,333 | |
Jul 25 2013 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | D | 0.20 | 2,500,000 | 500,000 | 0 | |
Jul 25 2013 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | D | 0.20 | 5,000,000 | 1,000,000 | 0 | |
Jul 25 2013 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | D | 0.15 | 4,640,000 | 696,000 | 0 | |
Jul 03 2013 | ALQA | Alliqua BioMedical ... | Harborview Value Master Fund, ... | - | Option Exercise | A | 0.10 | 617,284 | 59,877 | 617,284 | |
Jul 03 2013 | ALQA | Alliqua BioMedical ... | Harborview Value Master Fund, ... | - | Option Exercise | A | 0.20 | 500,000 | 100,000 | 500,000 |